Yep, I hear you, deep down you know placebos have mostly all crossed over by Dec. 15th,2016 presentation by Dr.Liau. As you noted Avastin is now approved as of 12/6/17 just a week ago for Rgbm based on PFS, so things are evolving to firm up PFS as approvable primary endpoint. FDA has not been as accommodating until just recently about PFS vs OS statistical significance endpoints. LP & LL have been cautious and with good reason as the spin doctors are always spinning GOOD into BAD. Deep down you know with 84 PFS patients in Jan 2017 we are near the end of the trial and readout. I feel comfortable they have control of the situation with the last two dilutions to maintain control of the company. I accept they will have readout when all details have been resolved, clinical hold, lawsuits, data collection. Happy Holidays! I have accepted it is what it is and things could be much worse like we didn't have those 99 patients still alive! I am grateful we are still waiting for top-line readout and the longer it takes the better for patients.... LP took shares instead of CASH, that is Confidence It is only fair she gets the same price as the MM dictate. Caveat Emptor... She takes responsibility so should everyone else. Just go with the flow bro.... being grateful is a better perspective to take imho... Merry Christmas!
News 
Market Data 
Discover 
